Silencing ARL11 relieved atherosclerotic inflammation and lipid deposition via retraining JAK2/STAT1 pathway.
Yanhua ZhenJiaqi YangJi SongZeyu XingJiahe Zheng
Published in: Atherosclerosis (2024)
ARL11 promoted the development of AS via interacting with JAK2 and activating JAK2/STAT1 pathway. Thus, silencing ARL11 may prevent the process of AS and be a novel way to treat AS.